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ABSTRACT U6 small nuclear RNA (snRNA) is an essen-
tial factor in mRNA splicing. On the basis of the high conser-
vation of its sequence, it has been proposed that U6 suRNA may
function catalytically during the splicing reaction. If this is the
case, it is likely that U6 snRNA interacts with the splice sites in
the spliceosome to catalyze the reaction. We have used UV
crosslinking to analyze the interactions of U6 snRNA with the
splicing substrates during the yeast splicing reaction.
Crosslinked products in which the central region ofU6 snRNA
was joined to the 5' splice site region of mRNA precursor and
lariat intermediate were identified. The crosslinking sites were
precisely located in one of these products. The results suggest
a possible base-pairing interaction between U6 snRNA and the
5' splice site of the mRNA precursor.
In nuclear pre-mRNA splicing, a number of factors including
five small nuclear ribonucleoproteins (snRNPs) assemble on
the mRNA precursor (pre-mRNA) in an ordered pathway to
form a large RNP complex called the spliceosome (1-3). In
this complex, the intron is excised in a two-step reaction. The
first step involves the cleavage at the 5' splice site and the
formation of a lariat structure. In the second step, the 3'
splice site is cleaved and concomitantly the 5' exon is ligated
to the 3' exon. This two-step reaction is fundamentally
similar to the self-splicing pathway ofgroup II introns, which
is known to be catalyzed by the intron itself (4, 5). This has
led to the hypothesis that the mechanisms of pre-mRNA
splicing and self-splicing are related and that pre-mRNA
splicing is RNA-catalyzed (6-8). Although no conserved
secondary structures have been reported in pre-mRNA in-
trons, small nuclear RNAs (snRNAs) are known to partici-
pate in the splicing reaction as trans-acting components.
Therefore, it has been argued that snRNAs might interact
with each other and/or with pre-mRNA to form the structure
that catalyzes the splicing reaction.
Several RNA-RNA interactions are known to be involved
in mRNA splicing. U1 snRNA interacts with the 5' splice site
by base pairing at an early stage in the spliceosome assembly
pathway (9-11). This interaction is apparently destabilized
after spliceosome formation (12-14). Recently U1 snRNA
was also shown to base pair with the 3' splice site in
Schizosaccharomyces pombe (15). U2 snRNA base pairs
with the branch point (16-18). A study of cryptic splice site
activation in Saccharomyces cerevisiae suggests that U5
snRNA interacts with the exon sequences at the 5' and 3'
splice sites (19). U4 and U6 snRNAs base pair with each other
in the U4/U6 snRNP (20-22). This base-pairing interaction is
destabilized after the entry of this snRNP into the spliceo-
some prior to the first-step reaction (23-25). In the mamma-
lian system, base pairing between the 5'-end region of U2
snRNA and the 3'-end region of U6 snRNA has also been
demonstrated (26, 27).
A good deal of circumstantial evidence links U6 to the
catalytic center of the spliceosome. It is the most highly
conserved of the snRNAs (60%6 sequence identity between
yeast and mammal) (28). Mutations in highly conserved
sequences in U6 block the first step or the second step of the
splicing reaction both in vitro and in vivo (29, 30). There is
also the intriguing observation of introns in the U6 gene of
certain fungi, suggesting an insertion of the substrate into the
catalyst (31-33). If U6 is a part of the catalytic center, it
should be in close proximity to the intron. Sawa and Shimura
(34) demonstrated an interaction between U6 and the 5' splice
site region in the mammalian system. For technical reasons,
the specificity of the crosslink could not be precisely deter-
mined. In this report we have used the same technique to
identify crosslinked products between U6 and the intron in
the yeast system. The location of the crosslinks was mapped
precisely in both molecules. The results indicate a potential
for a base-pairing interaction between U6 snRNA and a
conserved sequence near the 5' splice site of the intron. The
formation of such a structure could be an essential prelude to
catalysis, since it would position essential conserved residues
in U6 RNA in close proximity to the 5' splice site.
MATERIALS AND METHODS
UV-Crosslinking Experiments. Preparation of yeast whole-
cell extract from SS330 strains (35) and in vitro synthesis of
actin pre-mRNA (36) were carried out as described. Standard
splicing reactions were performed as described (24) in 40-Al
reaction mixtures or in 1- to 2-ml reaction mixtures for
large-scale crosslinking experiments. After incubation, the
reaction mixtures were diluted 1:5 to 1:20 with buffer E [12
mM Hepes-KOH, pH 7.0/30mM KC1/3 mM MgCl2/0.12mM
EDTA/12% (vol/vol) glycerol] to minimize nonspecific
crosslinking. The diluted reaction mixtures were then UV-
irradiated (wavelength, 254 nm; GTE, G1ST8) for 2 min on a
microtiter plate on ice at a distance of 3 cm from the lamp
(-4000 ,uW/cm2). The RNAs were recovered from the irra-
diated samples as described (34). Annealing of the
crosslinked products with a biotinylated oligonucleotide and
binding to streptavidin-agarose (GIBCO/BRL) were carried
out as described (34). The oligonucleotide [U6a, complemen-
tary to nucleotides (nt) 84-99 ofU6 snRNA] was biotinylated
at its 5' end with Biotin-ON phosphoramidite (Clontech)
during synthesis. After binding, agarose beads were washed
six times with 5-10 vol of buffer G (0.6 M KCI/20 mM
Hepes-KOH, pH 7.0/0.2mM EDTA), and bound RNAs were
eluted by incubation with buffer D (20 mM Hepes-KOH, pH
7.0/50 mM KCI/0.2 mM EDTA/20%o glycerol) at 65°C for 3
min. Selected RNAs were analyzed by electrophoresis on a
5% polyacrylamide gel containing 8 M urea. For the large-
scale crosslinking experiments, the bands corresponding to
the crosslinked products were excised and RNAs were eluted
Abbreviations: snRNA, small nuclear RNA; nt, nucleotide(s); snRNP,
small nuclear ribonucleoprotein.
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from the gel in RNA elution buffer (0.5 M NaOAc, pH 5.3/1
mM EDTA/0.1% SDS).
Analysis of Crosslinked Products. RNase H-digestion ex-
periments were performed as described (34). Primer-
extension reaction mixtures with avian myeloblastosis virus
reverse transcriptase (Promega) contained about 0.01 fmol of
RNA and 40 fmol ofprimer and experiments were performed
as described (37). After the reaction, the RNA template was
hydrolyzed with 0.1 M NaOH at 650C for 1 hr and the DNA
extension products were separated electrophoretically on an
8% polyacrylamide gel containing 8 M urea. The radioactivity
in the gel was detected using a Phosphorlmager (Molecular
Dynamics, Sunnyvale, CA).
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RESULTS
Crosslinked Products of U6 snRNA. To analyze the inter-
action of U6 snRNA and pre-mRNA during the splicing
reaction, the in vitro splicing reaction was carried out with a
yeast extract and 32P-labeled actin pre-mRNA. Then the
reaction mixture was UV-irradiated. After irradiation, the
RNAs were isolated by proteinase treatment and phenol
extraction. Crosslinked products of U6 snRNA were exten-
sively enriched by an affinity selection using a biotinylated
oligonucleotide complementary to U6 snRNA and streptavi-
din-agarose. The bound RNAs were eluted and analyzed by
gel electrophoresis (Fig. 1A).
In the reaction mixture incubated for 3 min, two
crosslinked products (designated U6-preI and U6-prell) were
observed in addition to pre-mRNA (Fig. 1A, lane 1). These
products had quite similar electrophoretic mobilities and
were difficult to reproducibly separate (data not shown). At
3 min, the first step of the reaction had not occurred,
indicating that these products must be U6 crosslinked to
pre-mRNA. The amounts of U6-prel and U6-preII decreased
after a 10-min incubation (lanes 4 and 5). After the first step
of the reaction had occurred (5 min), an additional U6
crosslink was observed (designated U6-2/3). This product
was cleaved by RNase H when incubated with oligonucleo-
tides specific for the intron (Fig. 1B, lane 3) or the 3' exon
(lane 4) but was not cleaved with an oligonucleotide com-
plementary to the 5' exon (lane 2). This suggests that U6-2/3
contains a crosslink between U6 snRNA and the lariat
intermediate. To confirm this, a primer-extension experiment
was carried out with uncrosslinked lariat intermediate or
U6-2/3 purified by electrophoresis (Fig. 1C). The oligode-
oxynucleotide primer in this reaction was complementary to
the 3' splice site region. With both RNAs, extension by
reverse transcriptase was blocked at the branch point, re-
sulting in a 51-nt extension product. This clearly shows that
U6-2/3 is a lariat structure. Because this product was cleaved
by RNase H with the 3' exon oligonucleotide (Fig. 1B, lane 4),
U6-2/3 contains a crosslink between U6 snRNA and the lariat
intermediate, and not the lariat intron. These U6-crosslinked
products could not be selected with biotinylated oligonucleo-
tides complementary to U1, U2, U4, or U5 snRNAs (data not
shown), suggesting that the products do not contain other
snRNAs. Failure to detect crosslinks with more than one
snRNA may be due to the low efficiency ofcrosslinking in our
conditions. Less than 0.01% of the starting pre-mRNA was
found in the U6-crosslinked products.
The fact that the crosslinked products described above are
not selected when the purification is carried out in the
absence of a complementary oligonucleotide (data not
shown) confirms that they contain U6 sequences. These
products were not formed when the splicing reaction was
carried out in the absence ofATP (Fig. 1A, lane 6), indicating
that formation of the spliceosome is required.
Mapping of the Crossfinking Sites by RNase H Digestion.
The location of the crosslinks in U6-prel and U6-preII was
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FIG. 1. Identification of crosslinked products of U6 snRNA. (A)
Splicing reactions were performed in the standard conditions (lanes
1-5) or in the absence of ATP (lane 6) for the time indicated above
each lane (15 min for lane 6), and then UV crosslinking was
performed. The products were electrophoresed on a denaturing 5%
polyacrylamide gel and then subjected to autoradiography. (B)
UV-crosslinking experiment was performed after a 5-min splicing
reaction. Then, the RNAs selected with a biotinylated U6 oligonu-
cleotide were digested by RNase H with oligonucleotides comple-
mentary to the 5' exon (lane 2, 5'E in Fig. 2A), intron (lane 3, Int in
Fig. 2A), or 3' exon (lane 4, nt +1 to +16 downstream ofthe 3' splice
site) or without oligonucleotides (lane 1). The digestion products
were analyzed as in A. The bands of crosslinked products are
indicated and the positions of lariat intermediate and pre-mRNA are
schematically shown. (C) U6-2/3 and lariat intermediate (2/3 inter-
mediate) were purified after large-scale crosslinking experiments and
used as templates for primer-extension experiments. The primer was
complementary to the 3' splice site region (nt -8 to +8 relative to the
3' splice site). The extension products were electrophoresed with
end-labeled Msp I digests of pBR322 DNA (lane Marker) and
end-labeled products of dideoxynucleotide sequencing reactions of
an SP6-actin plasmid (38) performed with the same primer (lanes G,
A, C, and T). The letters to the right of the gel show the RNA
sequence and are complementary to the sequencing ladder. The
position of the branch site is indicated by an asterisk.
determined by RNase H mapping. As mentioned above, the
separation of these crosslinked products was not reproduc-
ible. This time we used a mixture of the products purified by
electrophoresis. This mixture probably contained about
equal amounts of U6-prel and U6-preIl, because we always
detected similar amounts of them when they were distin-
guishable on the gel (Fig. 1A and data not shown). The
mixture of U6-prel and U6-preIl was digested by RNase H
directed by oligonucleotides complementary to a portion of
the 5' exon or intron near the 5' splice site (oligonucleotides
5'E or Int). The digestion products were separated by elec-
trophoresis using the digestion products of uncrosslinked
pre-mRNA as markers (Fig. 2A). When oligonucleotide 5'E
was used, a small fragment corresponding to the 5' portion of
pre-mRNA relative to the cleavage site (5' fragment of
pre-mRNA) was generated from the mixture of U6-prel and
U6-prell and from uncrosslinked pre-mRNA. This indicates
that the crosslinking sites are not in this fragment. The
digestion product containing the 3' fragment of pre-mRNA
was detected as a slowly migrating RNA (lane 5'E). There-
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FIG. 2. RNase H-digestion experiments of the crosslinked prod-
ucts. (A) Pre-mRNA or the mixture of U6-preI and U6-prell purified
after large-scale crosslinking experiment was digested by RNase H
with oligonucleotides 5'E (complementary to nt -32 to -17 upstream
of the 5' splice site) or Int (complementary to nt +41 to +56
downstream ofthe 5' splice site) or without oligonucleotides (lane no
oligo). The digestion products were analyzed as in Fig. 1A. (B and
C) Mixtures ofU6-preI and U6-prell (B) or U6-2/3 (C) were digested
by RNase H with U6a (complementary to nt 84-99 ofU6 snRNA) or
U6dl (complementary to nt 28-54 ofU6 snRNA) oligonucleotides or
without oligonucleotides (lane no oligo). Digestion products were
analyzed as in Fig. 1A.
fore, the crosslinking sites in U6-prel and U6-preII are
downstream of the region complementary to oligonucleotide
5'E. In contrast, RNase H digestion directed by oligonucle-
otide Int efficiently produced the 3' fragment of pre-mRNA,
indicating that the crosslinking sites are upstream of the Int
region. Therefore, the crosslinking sites in U6-prel and
U6-prell are between the 5'E and Int regions. These results
also confim that the U6-prel and U6-prell species contain
intact pre-mRNA and not the intermediates orproducts ofthe
splicing reaction, since RNase H digestion ofthe crosslinked
products at either side of the crosslinking sites gave rise to
linear RNA fragments with the same mobilities as those
obtained by RNase H digestion of intact uncrosslinked pre-
mRNA.
To analyze the crosslinking sites on U6 snRNA, the
mixture of U6-prel and U6-preII was cleaved by RNase H
with two oligonucleotides complementary to U6 snRNA (Fig.
2B). RNase H cleavage directed by oligonucleotide U6a,
complementary to a region near the 3' end ofU6 snRNA, led
to a product with slightly increased mobility relative to the
uncleaved crosslinked product. In contrast, digestion di-
rected by oligonucleotide U6dl, which is complementary to
the central region of U6 snRNA (see Fig. 4), gave rise to a
product with the same mobility as uncrosslinked pre-mRNA.
Since this cleavage product contains intact pre-mRNA, this
result indicates that most of U6 snRNA was removed by
digestion with oligonucleotide U6dl. This can be explained
by assuming that oligonucleotide U6dl hybridized with U6
snRNA on both sides of the crosslinking site and that both
arms were cleaved by RNase H. Consequently, the crosslink-
ing sites of U6-prel and U6-preII should be in the U6dl
region. This is also the case with U6-2/3. When purified
U6-2/3 was cleaved in response to oligonucleotide U6dl, the
mobility of the cleavage product was similar to that of lariat
intermediate (Fig. 2C). Therefore, the crosslinking site in
U6-2/3 is also in the U6dl region.
Determination ofthe Crosslinking Sites by Primer-Extension
Analyses. To localize the crosslinking sites more precisely,
we performed primer-extension experiments. In these exper-
iments, reverse transcriptase was expected to stop 1 nt before
the crosslink as in stops caused by the 2'-3' phosphodiester
bond at the branch site (see Fig. 1C) and by chemically
modified nucleotides (39). Mapping ofcrosslinks in U6 snRNA
was performed using the 5'-end-labeled oligonucleotide U6a as
a primer (Fig. 3A). With U6-2/3, five nearly consecutive
strong stops were observed. These signals indicate that re-
verse transcriptase extension was blocked at positions 39 and
41-44 on U6 snRNA (indicated by small dots in the figure). A
signal corresponding to a block at A40 was not detected. The
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FIG. 3. High-resolution mapping of the crosslinking sites by
primer-extension analysis. The crosslinked products, pre-mRNA,
and lariat intermediate were purified after large-scale crosslinking
experiments. U6 snRNA was isolated from the irradiated reaction
mixture by proteinase treatment and affinity selection with the
biotinylated U6 oligonucleotide. These RNAs were used for primer-
extension analyses with end-labeled oligonucleotides U6a (A) or Int
(B) as primers. For each reaction, 0.01 fmol of pre-mRNA, lariat
intermediate, or U6-2/3 or 0.004 fmol of U6 prel or U6-prell was
used. Marker, DNA sequencing with the U6a (A) or Int (B) primers
and letters adjacent to the gel was the same as in Fig. 1C. Small dots
adjacent to the RNA sequences indicate positions of reverse tran-
scriptase stops in the U6-2/3 template. In addition to the stops at
positions 39-43 in U6, we also note another band corresponding to
a block at position 19 (A, lane U6-2/3). There is no evidence for this
minor crosslinked product in the RNase H-mapping experiment (Fig.
2C). Further experiments will be required to determine whether this
is a significant crosslink site.
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absence of this stop makes it unlikely that reverse transcrip-
tase is fortuitously blocked at multiple positions near a
crosslinking site. These blocks were not observed in un-
crosslinked U6 snRNA affinity-purified from an irradiated
splicing reaction mixture, excluding the possibility that they
are due to nonspecific damage of U6 snRNA caused by the
irradiation. These results suggest that U6-2/3 consists of five
crosslinked products that were not resolved by electrophore-
sis and that there are crosslinking sites at G39, A41, A42, C43,
and A44 in U6 snRNA. Consistent with the results of RNase
H-mapping experiments (Fig. 2C), these nucleotides are in the
U6d1 region (see Fig. 4). With U6-prell, similar extension
products were weakly observed, indicating that the crosslink-
ing sites are located at the same positions as in U6-2/3.
Although we failed to map precisely the crosslinking sites of
U6-prel by primer-extension analyses, RNase H-digestion
experiments show that the crosslinking sites are in the U6dl
region (Fig. 2B).
To map the crosslinking sites on pre-mRNA or the lariat
intermediate, we used oligonucleotide Int as a primer (Fig.
3B), because the crosslinking sites of U6-prel and U6-prell
were shown to be upstream of the Int region (Fig. 2A). With
U6-2/3, five consecutive signals were observed that indicate
reverse transcriptase blocks at nt +4 to +8 downstream of
the 5' splice site. These blocks did not occur when un-
crosslinked pre-mRNA or lariat intermediate was used as
template. The results again suggest that U6-2/3 consists of
five crosslinked products and indicate that the crosslinking
sites are at residues U+4, G+5, U+6, U+7, and C+8 in the
intron (the numbers indicate relative positions from the 5'
splice site). Insufficient U6-prel and -preII crosslinked prod-
ucts were obtained to allow mapping.
DISCUSSION
UV crosslinking has been widely used to characterize inter-
actions within and between RNA molecules (40). Generally,
the UV photoadducts join two bases that are in close prox-
imity due to tertiary structure and not base pairs in a helix.
For example, in a study of intrastrand crosslinks in UV-
irradiated 50S ribosomes, Mitchell et al. (41) characterized 10
crosslinks but only 1 crosslink was between nucleotides in a
helical region. Nonetheless, one can cite a number of studies
in which nucleotides in RNA known by other criteria to be
base paired are joined together in UV-induced crosslinks.
These include crosslinks between U4 and U6 snRNAs and
between U2 and U6 snRNAs, in the trypanosome system
(42), and between UI snRNA and the 5' splice site of the
intron and between U2 and the branch point of the intron, in
the mammalian system (34). In general, these intermolecular
crosslinks are in extremely low yield and the chemistry by
which they form is unknown. If the crosslinks are most likely
to form between stacked bases, then it is possible that UV
crosslinks form during the pairing or dissociation of a helix,
during rare structural perturbations of the helix, or when the
helix geometry is altered by interaction with a protein. The
presence of a UV crosslink between two bases most likely
indicates that they are at least in transient proximity to each
other but it neither proves nor disproves their occurrence in
a base pair.
The above discussion is relevant to the results we have
observed. We have isolated a collection of crosslinked spe-
cies in which a nearly contiguous set of bases in U6 RNA is
crosslinked to a complementary set ofbases in the intron near
the 5' splice site. Since these crosslinks require ATP to form
and since one of them occurs in a splicing intermediate, it is
highly likely that nt 39-44 in U6 are in close proximity to nt
+4 to +8 of the intron within the spliceosome. Since these
nucleotides are complementary, it seems reasonable that
they do pair (Fig. 4), although the UV crosslinks might not
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FIG. 4. Base-pairing model between U6 snRNA and pre-mRNA.
The sequences of the central region of U6 snRNA and the 5' splice
site region of actin pre-mRNA are shown. The highly conserved
ACAGAG sequence is in boldface italic type. The proposed base
pairings are indicated by short vertical lines. Stem I region, which
base pairs with U4 snRNA, is shown. The sites equivalent to the
insertion sites of the U6 snRNA introns of some organisms (32, 33)
are indicated by arrowheads. The consensus 5' splice site sequence
in yeast is shown below the figure.
have occurred when they were in that form.
After we had obtained these results, we were excited to
learn that Wassarman and Steitz (43) had also observed a
similar crosslink between U6 and the 5' splice site region of
the intron. Their work was in the mammalian system and
employed psoralen-induced crosslinking, which is more apt
to join base-paired regions. The crosslink they observed was
between C37 in U6 (equivalent to C43 in yeast U6 RNA) and
a T1 oligonucleotide in the adenovirus intron that spans the
region from positions +6 to +21 of the intron. If their
crosslink is, in fact, between C37 and the first base of this
oligonucleotide, their results could be identical to ours.
However, they propose a different base-pairing scheme in
which the highly conserved ACAGAG sequence in U6 pairs
with the intron at positions +2 to +7, a pairing 5 base pairs
out of register with ours. Since their crosslinked species is
between pre-mRNA and U6 and the one we have character-
ized is between the lariat intermediate and U6, an alternative
possibility is that both pairing schemes are correct and that
there is a conformational switch between the two steps of
splicing. In any case, the discovery of similar crosslinks
produced by different techniques in two phylogenetically
divergent splicing systems provides strong indication that
there is a functional association between U6 RNA and the 5'
splice site.
If this interaction includes pairing with bases +4 to +7 as
both we and Wassarman and Steitz (43) propose, then it
would replace at least a portion of the base pairing known to
occur between U1 snRNA and the 5' splice site, and it would
also replace the base pairing between U5 snR.NA and the
intron in this region proposed by Wassarman and Steitz (43)
from their psoralen-crosslinking results. These mutually ex-
clusive pairings appear to be a crucial feature of the splicing
process. The interaction between U1 and the 5' splice site is
an earlier step in spliceosome assembly but its function may
be restricted to splice-site recognition and this interaction
may be replaced in time by the U6 interaction in the fully
assembled spliceosome. It is attractive to hypothesize a role
for the RNA helicases, known to be essential factors in
splicing (2, 3), in the catalysis of these helical interchanges.
Ifboth U6 and U1 interact with the same nucleotides in the
5' splice site then the alteration of these nucleotides could
lead to complicated phenotypes. It has long been known that
G5 -s A mutation in the intron (termed A5) in actin and
ribosomal protein RP51A leads to aberrant splicing in vivo
(44-46). In the first step of the aberrant splicing, cutting and
Proc. Nad. Acad. Sci. USA 89 (1992)
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lariat formation take place 5 bases upstream in A5 actin
pre-mRNA and 3 bases upstream in the A5 RP51A pre-
mRNA. Compensatory mutations in U1 did not suppress
these aberrant cleavages (9, 10). It is an interesting possibility
that the A5 mutation that disrupts the pairing between U6 and
the intron causes the catalytic center to be positioned incor-
rectly and, therefore, to cut incorrectly. The suppression of
the A5 mutation may thus require changes in both U1 and U6.
It is likely, however, that the genetic dissection of the
U6-intron interaction will be difficult because individual base
substitutions in the region from G39 to A44 of U6 have no
effect either in vitro or in vivo (29, 30). A triple mutation of
the bases AAC (corresponding to nt 41-43 in yeast) to UUG
in Xenopus U6RNA severely inhibited splicing in the oocyte
complementation assay (47, 48). It may be that single-base
changes are not sufficient to disrupt the pairing between U6
and the intron.
The interaction proposed here between U6 snRNA and the
intron would position the highly conserved ACAGAG se-
quence (nt 47-52) very close to the 5' splice site (Fig. 4).
Mutations in this sequence have strong effects on either the
first or the second step of splicing, both in vitro and in vivo
(29, 30). It is an exciting possibility that the U6-intron
interaction is crucial to the formation of the active confor-
mation of the spliceosome and that Fig. 4 represents a
snapshot of the RNA secondary structure in a part of that
complex at some point along the reaction pathway. It is
important to know which point. From our results, it is likely
that the interaction exists in similar form, both before and
after the first step of splicing; however, there could be
important but subtle changes that occur after the first step.
Temperature-sensitive mutations in the PRP genes required
for pre-mRNA splicing allow us to dissociate the process into
a number of stages (3, 24). We should be able to use these
tools to determine the time in the assembly and reaction
pathway in which RNA interactions, as determined through
crosslinks, occur. Due to the low efficiency, UV crosslinking
will probably not be the tool of choice for these experiments.
Wyatt, Sontheimer, and Steitz (personal communication)
have employed the ligation tools developed by Moore and
Sharp (49) to position base analogues containing photo-
induced crosslinking groups into unique positions of pre-
mRNA. Using this technique they have demonstrated spe-
cific crosslinks between pre-mRNA and U5 snRNA. It is
clear that this technology can now be applied more broadly
to provide a comprehensive picture of the RNA interactions
in the spliceosome as it is assembled and as it functions.
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